Literature DB >> 22213310

Vitamin D: potential in the prevention and treatment of lung cancer.

Rosemary Norton1, Maria A O'Connell.   

Abstract

Vitamin D is a steroid hormone traditionally recognized for maintaining calcium and phosphorous homeostasis in the body. However, it is now widely accepted that it exerts several extraskeletal actions, including anti-tumorigenic and immunomodulatory effects in vitro and in vivo. There is now a huge interest in studying the modes of action of vitamin D in a wide range of infectious and chronic disease settings and its potential in cancer prevention and treatment is currently under detailed investigation. In relation to the lung, evidence from observational studies, animal models and in vitro cell culture suggest that vitamin D may play a beneficial role in pulmonary inflammation. In addition, an adequate vitamin D status may be important for lung cancer prevention. Furthermore, vitamin D or its analogs, alone or in combination with cytotoxics, have potential in the treatment of lung cancer. Vitamin D is converted to its active form locally in the lung, suggesting that it may play an important role in lung health. Here, we review the evidence from observational, clinical and experimental studies in relation to vitamin D and lung cancer. In addition, we discuss vitamin D resistance in lung tumors and the potential molecular mechanisms of vitamin D action in lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213310

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model.

Authors:  Sarah A Mazzilli; Pamela A Hershberger; Mary E Reid; Paul N Bogner; Kristopher Atwood; Donald L Trump; Candace S Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

Review 2.  Association between vitamin D and hepatitis C virus infection: a meta-analysis.

Authors:  Livia Melo Villar; José Antonio Del Campo; Isidora Ranchal; Elisabeth Lampe; Manuel Romero-Gomez
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.

Authors:  Qiuhong Zhang; Beatriz Kanterewicz; Suzanne Shoemaker; Qiang Hu; Song Liu; Kristopher Atwood; Pamela Hershberger
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-28       Impact factor: 4.292

4.  Mesenchymal and stem-like cell properties targeted in suppression of chronically-induced breast cell carcinogenesis.

Authors:  Kusum Rathore; Hwa-Chain Robert Wang
Journal:  Cancer Lett       Date:  2013-01-22       Impact factor: 8.679

5.  Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Su-Chun Cheng; Tianxi Cai; Andrew Cagan; Vivian S Gainer; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-23       Impact factor: 11.382

6.  Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.

Authors:  Saurabh Singhal; Harit Kapoor; Saravanan Subramanian; Devendra K Agrawal; Sumeet K Mittal
Journal:  J Gastrointest Cancer       Date:  2019-12

7.  Reduced Lung Cancer Mortality With Lower Atmospheric Pressure.

Authors:  Ray M Merrill; Aaron Frutos
Journal:  Dose Response       Date:  2018-04-16       Impact factor: 2.658

8.  Calcitriol Inhibits Viability and Proliferation in Human Malignant Pleural Mesothelioma Cells.

Authors:  Iacopo Gesmundo; Francesca Silvagno; Dana Banfi; Valentina Monica; Alessandro Fanciulli; Giacomo Gamba; Noemi Congiusta; Roberta Libener; Chiara Riganti; Ezio Ghigo; Riccarda Granata
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-08       Impact factor: 5.555

9.  Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model.

Authors:  Ewa Maj; Beata Filip-Psurska; Marta Świtalska; Andrzej Kutner; Joanna Wietrzyk
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

10.  Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.

Authors:  Ewa Maj; Beata Filip-Psurska; Magdalena Milczarek; Mateusz Psurski; Andrzej Kutner; Joanna Wietrzyk
Journal:  Int J Oncol       Date:  2017-12-15       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.